We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SRG:MILSnam S.p.A. Analysis

Data as of 2026-06-13 - not real-time

€6.43

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Snam S.p.A. trades at €6.43, sitting just above its 20‑day SMA (6.31) but below the 50‑day SMA (6.49), indicating a modest short‑term upside while the broader trend remains neutral. The RSI of 55 suggests the stock is neither overbought nor oversold, and the MACD histogram is positive, giving the technical signal a mild bullish bias. Fundamentally, the company posts strong operating margins (48% operating, 27% net) and a robust EBITDA of €2.96 bn, with adjusted EBITDA up 9% YoY in Q1 2026. However, the balance sheet is heavily leveraged (debt‑to‑equity 193%) and free cash flow is zero, raising concerns about the sustainability of its 4.72% dividend payout (82% of earnings). The valuation is mixed: a forward P/E of 14.7 is below the industry average (20.5) and the dividend yield is attractive, yet the DCF‑derived fair value (€3.19) is less than half the market price, implying the stock is currently overvalued. Volatility sits at 17.5% over the past 30 days, beta is near zero, and volume is decreasing, suggesting limited market liquidity and a potential price correction. Recent earnings highlight steady growth and strategic investments, but net debt rose to €18.5 bn, underscoring the need for careful monitoring of leverage.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance with neutral technical trend
  • High dividend yield but elevated payout ratio
  • Decreasing trading volume indicating liquidity pressure

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Steady earnings growth and strong operating margins
  • Heavy debt load limiting financial flexibility
  • Attractive dividend yield offset by leverage concerns

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Regulated utility business provides stable cash flows
  • DCF fair value far below current price suggests overvaluation risk
  • Strategic investments and asset diversification across Europe

Key Metrics & Analysis

Financial Health

Revenue Growth3.00%
Profit Margin27.36%
P/E Ratio17.9
ROE11.23%
ROA4.13%
Debt/Equity193.10
P/B Ratio2.3
Op. Cash Flow€2.8B
Industry P/E20.5

Technical Analysis

TrendNeutral
RSI55.7
Support€6.13
Resistance€6.46
MA 20€6.31
MA 50€6.49
MA 200€5.89
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair Value€3.19
Target Price€6.50
Upside/Downside1.06%
GradeOvervalued
TypeBlend
Dividend Yield4.72%

Risk Assessment

Beta-0.04
Volatility17.45%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.